Clinical Trial to Evaluate the Efficacy and Safety of 'GLA5PR GLARS-NF1 Tab.' in Peripheral Neuropathic Pain

Clinical trial NCT03221907 · COMPLETED

Trial details

NCT number: NCT03221907
Sponsor: Daewon Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pain of Mononeuropathy

Start date: 2016-04-11
Primary completion: 2019-01-08
Enrollment: 352

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.